Medtelerad Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.30 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 56.76%
- Profit Growth 99.06%
- Ebitda 91.08%
- Net Worth 119.64%
- Total Assets 60.10%
About Medtelerad Technologies
Medtelerad Technologies Private Limited (MTPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 April 2018 (Six years and ten months 9 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Snehalata Mishra and Rajesh Mishra serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999WB2018PTC225714
- Company No.
225714
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Medtelerad Technologies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Mishra  | Director | 18-Apr-2018 | Current |
| Snehalata Mishra | Director | 18-Apr-2018 | Current |
Financial Performance of Medtelerad Technologies.
Medtelerad Technologies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 56.76% increase. The company also saw a substantial improvement in profitability, with a 99.06% increase in profit. The company's net worth Soared by an impressive increase of 119.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medtelerad Technologies?
Unlock access to Medtelerad Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Medtelerad Healthcare Private LimitedSnehalata Mishra and Rajesh Mishra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medtelerad Technologies?
Unlock and access historical data on people associated with Medtelerad Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medtelerad Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medtelerad Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.